关注
Kartik Kumar
Kartik Kumar
在 imperial.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Epidemiology and clinical management of Legionnaires' disease
N Phin, F Parry-Ford, T Harrison, HR Stagg, N Zhang, K Kumar, ...
Lancet Infectious Diseases 14 (10), 1011-1021, 2014
4692014
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
T Kotecha, DS Knight, Y Razvi, K Kumar, K Vimalesvaran, G Thornton, ...
European Heart Journal 42 (19), 1866-1878, 2021
3712021
Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
K Kumar, TSC Hinks, A Singanayagam
American Journal of Physiology-Lung Cellular and Molecular Physiology 318 (6 …, 2020
522020
Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series
K Kumar, MR Loebinger
CHEST 161 (3), 637-646, 2022
422022
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
J Brown, K Kumar, J Reading, J Harvey, S Murthy, S Capocci, S Hopkins, ...
European Respiratory Journal 50 (4), 1701267, 2017
372017
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
K Kumar, CL Daley, DE Griffith, MR Loebinger
European Respiratory Review 31 (163), 210212, 2022
332022
Diagnosis and treatment of tuberculosis: latest developments and future priorities
K Kumar, OM Kon
Annals of Research Hospitals 1 (37), 1-15, 2017
302017
Clinical implications of the global multidrug-resistant tuberculosis epidemic
K Kumar, I Abubakar
Clinical Medicine 15 (6), s37-s42, 2015
272015
Skin testing with raw egg does not predict tolerance to baked egg in egg‐allergic children
PJ Turner, K Kumar, AT Fox
Pediatric Allergy and Immunology 25 (7), 657-661, 2014
272014
Repurposing Existing Drugs for the Treatment of COVID-19
H Farne, K Kumar, AI Ritchie, LJ Finney, SL Johnston, A Singanayagam
Annals of the American Thoracic Society 17 (10), 1186-1194, 2020
242020
Diagnosis and management of non-cystic fibrosis bronchiectasis
L Macfarlane, K Kumar, T Scoones, A Jones, MR Loebinger, R Lord
Clinical Medicine 21 (6), e571-e577, 2021
142021
Symptomatic, biochemical and radiographic recovery in patients with COVID-19
P Mallia, J Meghji, B Wong, K Kumar, V Pilkington, S Chhabra, B Russell, ...
BMJ Open Respiratory Research 8 (1), e000908, 2021
132021
Mycobacterium avium complex (MAC) genomics and transmission in a London hospital
AJ van Tonder, HC Ellis, CP Churchward, K Kumar, N Ramadan, ...
European Respiratory Journal 61 (4), 2201237, 2023
92023
Educational opportunities for postgraduate medical trainees during the COVID-19 pandemic: deriving value from old, new and emerging ways of learning
K Kumar, K Groom, L Martin, GK Russell, SL Elkin
Postgraduate Medical Journal 98 (1159), 328-330, 2022
92022
Respiratory Virus Infections in Asthma: Research Developments and Therapeutic Advances.
K Kumar, A Singanayagam, SL Johnston
Acta Medica Academica 49 (2), 130-143, 2020
92020
Clinical implications of the global multidrug-resistant tuberculosis epidemic
K Kumar, I Abubakar
Clinical Medicine 16 (6), 565-570, 2016
92016
Respiratory specialists working in different ways: Development of a GP hotline and respiratory support service during the COVID-19 pandemic
K Kumar, V Mak, K Groom, Y Razak, JL Brown, T Hyde, A Bokobza, ...
Future Healthcare Journal 7 (3), e88-92, 2020
82020
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
K Kumar, OM Kon
Microorganisms 9 (11), 2220, 2021
72021
Asymptomatic pyogenic liver abscesses secondary to Fusobacterium nucleatum and Streptococcus vestibularis in an immunocompetent patient
H Houston, K Kumar, S Sajid
BMJ Case Reports 2017, bcr-2017-221476, 2017
72017
A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum
K Kumar, A Gill, R Shafei, JL Wright
BMJ Case Reports 2014, bcr2014205331, 2014
62014
系统目前无法执行此操作,请稍后再试。
文章 1–20